Process dissociation analyses of memory changes in healthy aging, preclinical, and very mild Alzheimer disease: Evidence for isolated recollection deficits

Alzheimer disease biomarkers are associated with decline in subjective memory, attention, and spatial navigation ability in clinically normal adults

OBJECTIVE

Subtle changes in memory, attention, and spatial navigation abilities have been associated with preclinical Alzheimer disease (AD). The current study examined whether baseline AD biomarkers are associated with self- and informant-reported decline in memory, attention, and spatial navigation.

METHOD

Clinically normal (Clinical Dementia Rating Scale (CDR®) = 0) adults aged 56-93 (N = 320) and their informants completed the memory, divided attention, and visuospatial abilities (which assesses spatial navigation) subsections of the Everyday Cognition Scale (ECog) annually for an average of 4 years. Biomarker data was collected within (±) 2 years of baseline (i.e., cerebrospinal fluid (CSF) p-tau181/Aβ42 ratio and hippocampal volume). Clinical progression was defined as CDR > 0 at time of final available ECog.

RESULTS

Self- and informant-reported memory, attention, and spatial navigation significantly declined over time (ps < .001). Baseline AD biomarkers were significantly associated with self- and informant-reported decline in cognitive ability (ps < .030), with the exception of p-tau181/Aβ42 ratio and self-reported attention (p = .364). Clinical progression did not significantly moderate the relationship between AD biomarkers and decline in self- or informant-reported cognitive ability (ps > .062). Post-hoc analyses indicated that biomarker burden was also associated with self- and informant-reported decline in total ECog (ps < .002), and again clinical progression did not significantly moderate these relationships (ps > .299).

CONCLUSIONS

AD biomarkers at baseline may indicate risk of decline in self- and informant-reported change in memory, attention, and spatial navigation ability. As such, subjectively reported decline in these domains may have clinical utility in tracking the subtle cognitive changes associated with the earliest stages of AD.

Clinical utility of self- and informant-reported memory, attention, and spatial navigation in detecting biomarkers associated with Alzheimer disease in clinically normal adults

OBJECTIVE

Preclinical Alzheimer disease (AD) has been associated with subtle changes in memory, attention, and spatial navigation abilities. The current study examined whether self- and informant-reported domain-specific cognitive changes are sensitive to AD-associated biomarkers.

METHOD

Clinically normal adults aged 56-93 and their informants completed the memory, divided attention, and visuospatial abilities (which assesses spatial navigation) subsections of the Everyday Cognition Scale (ECog). Reliability and validity of these subsections were examined using Cronbach's alpha and confirmatory factor analysis. Logistic regression was used to examine the ability of ECog subsections to predict AD-related biomarkers (cerebrospinal fluid (CSF) ptau181/Aβ42 ratio (N = 371) or hippocampal volume (N = 313)). Hierarchical logistic regression was used to examine whether the self-reported subsections continued to predict biomarkers when controlling for depressive symptomatology if available (N = 197). Additionally, logistic regression was used to examine the ability of neuropsychological composites assessing the same or similar cognitive domains as the subsections (memory, executive function, and visuospatial abilities) to predict biomarkers to allow for comparison of the predictive ability of subjective and objective measures.

RESULTS

All subsections demonstrated appropriate reliability and validity. Self-reported memory (with outliers removed) was the only significant predictor of AD biomarker positivity (i.e., CSF ptau181/Aβ42 ratio; p = .018) but was not significant when examined in the subsample with depressive symptomatology available (p = .517). Self-reported memory (with outliers removed) was a significant predictor of CSF ptau181/Aβ42 ratio biomarker positivity when the objective memory composite was included in the model.

CONCLUSIONS

ECog subsections were not robust predictors of AD biomarker positivity.

Relationships between hourly cognitive variability and risk of Alzheimer's disease revealed with mixed-effects location scale models

OBJECTIVE

Observational studies on aging and Alzheimer's disease (AD) typically focus on mean-level changes in cognitive performance over relatively long periods of time (years or decades). Additionally, some studies have examined how trial-level fluctuations in speeded reaction time are related to both age and AD. The aim of the current project was to describe patterns of variability across repeated days of testing as a function of AD risk in cognitively normal older adults.

METHOD

The current project examined the performance of the Ambulatory Research in Cognition (ARC) smartphone application, a high-frequency remote cognitive assessment paradigm, that administers brief tests of episodic memory, spatial working memory, and processing speed. Bayesian mixed-effects location scale models were used to explore differences in mean cognitive performance and intraindividual variability across 28 repeated sessions over a 1-week assessment interval as function of age and genetic risk of AD, specifically the presence of at least one apolipoprotein E (APOE) ε4 allele.

RESULTS

Mean performance on processing speed and working memory was negatively related to age and APOE status. More importantly, e4 carriers exhibited increased session-level variability on a test of processing speed compared to noncarriers. Age and education did not consistently relate to cognitive variability, contrary to expectations.

CONCLUSION

Preclinical AD risk, defined as possessing at least one APOE ε4 allele, is not only associated with mean-level performance differences, but also with increases in variability across repeated testing occasions particularly on a test of processing speed. Thus, cognitive variability may serve as an additional and important indicator of AD risk. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

The dual-process perspective and the benefits of retrieval practice in younger and older adults

The testing effect is often considered a recollection-related phenomenon. However, recent work has observed a benefit of testing to both recollection and familiarity on immediate and delayed final tests. Further, although aging populations show marked declines in recollection, older and younger adults often benefit similarly from testing. This finding suggests that the testing effect in older adults may function via relatively preserved familiarity and lends further support to the hypothesis that the testing effect does not function solely via recollection-related processes. The current study builds on this work to better understand the mechanisms from the dual-process perspective that underlie the testing effect in both younger and older adults. To this end, younger (18-22 year old) and older (65-82 year old) adults studied words, took cued-recall tests on half of the words, and took a final Remember-Know recognition test on all words immediately or after a 1-day delay. At both delays, older and younger adults exhibited a testing effect in both recollection and familiarity, although the magnitude of the testing effect in recollection was reduced for older relative to younger adults. Implications for theories of the testing effect and its application in older adult populations are explored.

Brief Cognitive Tests for Distinguishing Clinical Alzheimer-Type Dementia From Mild Cognitive Impairment or Normal Cognition in Older Adults With Suspected Cognitive Impairment

BACKGROUND

The accuracy and harms of brief cognitive tests for identifying clinical Alzheimer-type dementia (CATD) are uncertain.

PURPOSE

To summarize evidence on accuracy and harms of brief cognitive tests for CATD in older adults with suspected cognitive impairment.

DATA SOURCES

Electronic bibliographic databases (from inception to November 2019) and systematic review bibliographies.

STUDY SELECTION

English-language, controlled observational studies in older adults that evaluated the accuracy of brief cognitive tests (standalone tests; memory, executive function, and language tests; and brief multidomain batteries) for distinguishing CATD from mild cognitive impairment (MCI) or normal cognition as defined by established diagnostic criteria. Studies with low or medium risk of bias (ROB) were analyzed.

DATA EXTRACTION

Two reviewers rated ROB. One reviewer extracted data; the other verified extraction accuracy.

DATA SYNTHESIS

Fifty-seven studies met analysis criteria. Many brief, single cognitive tests were highly sensitive and specific for distinguishing CATD from normal cognition. These included standalone tests (clock-drawing test, median sensitivity 0.79 and specificity 0.88 [8 studies]; Mini-Mental State Examination, 0.88 and 0.94 [7 studies]; Montreal Cognitive Assessment, 0.94 and 0.94 [2 studies]; and Brief Alzheimer Screen, 0.92 and 0.97 [1 study]), memory tests (list delayed recall, 0.89 and 0.94 [5 studies]), and language tests (category fluency, 0.92 and 0.89 [9 studies]). Accuracy was lower in distinguishing mild CATD from normal cognition and distinguishing CATD from MCI. No studies reported on testing harms.

LIMITATIONS

Studies were small. Few test metrics were evaluated by multiple studies. Few studies directly compared different tests, scores, cut points, or test combinations.

CONCLUSION

Many brief, single cognitive tests accurately distinguish CATD from normal cognition in older adults but are less accurate in distinguishing mild CATD from normal cognition or CATD from MCI. No studies reported on testing harms.

PRIMARY FUNDING SOURCE

Agency for Healthcare Research and Quality. (PROSPERO: CRD42018117897).

Multinomial models reveal deficits of two distinct controlled retrieval processes in aging and very mild Alzheimer disease

Dual-process models of episodic retrieval reveal consistent deficits of controlled recollection in aging and Alzheimer disease (AD). In contrast, automatic familiarity is relatively spared. We extend standard dual-process models by showing the importance of a third capture process. Capture produces a failure to attempt recollection, which might reflect a distinct error from an inability to recollect when attempted (Jacoby et al. Journal of Experimental Psychology: General, 134(2), 131-148, 2005a). We used multinomial process tree (MPT) modeling to estimate controlled recollection and capture processes, as well as automatic retrieval processes, in a large group of middle-aged to older adults who were cognitively normal (N = 519) or diagnosed with the earliest detectable stage of AD (N = 107). Participants incidentally encoded word pairs (e.g., knee bone). At retrieval, participants completed cued word fragments (e.g., knee b_n_) with primes that were congruent (e.g., bone), incongruent (e.g., bend), or neutral (i.e., &&&) to the target (e.g., bone). MPT models estimated retrieval processes both at the group and the individual levels. A capture parameter was necessary to fit MPT models to the observed data, suggesting that dual-process models of this task can be contaminated by a capture process. In both group- and individual-level analyses, aging and very mild AD were associated with increased susceptibility to capture, decreased recollection, and no differences in automatic influences. These results suggest that it is important to consider two distinct modes of attentional control when modeling retrieval processes. Both forms of control (recollection and avoiding capture) are particularly sensitive to cognitive decline in aging and early-stage AD.